CD274 and neoplasm: Treatment by merely anti‐PD‐L1 antibody, while could limit the MSI CRC tumor growth to 19‐fold, failed to suppress the growth of MSS CRC tumors, confirming that MSS CRC tumors were not sensitive to ICI therapy.